Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Preferred Dividend Payments: 2015-2019

Historic Preferred Dividend Payments for Outlook Therapeutics (OTLK) over the last 3 years, with Dec 2019 value amounting to $166,133.

  • Outlook Therapeutics' Preferred Dividend Payments rose 10.38% to $166,133 in Q4 2019 from the same period last year, while for Dec 2019 it was $640,613, marking a year-over-year decrease of 60.05%. This contributed to the annual value of $166,133 for FY2020, which is 73.42% down from last year.
  • Per Outlook Therapeutics' latest filing, its Preferred Dividend Payments stood at $166,133 for Q4 2019, which was up 2.50% from $162,081 recorded in Q3 2019.
  • Outlook Therapeutics' Preferred Dividend Payments' 5-year high stood at $1.1 million during Q3 2015, with a 5-year trough of $150,508 in Q4 2018.
  • Moreover, its 3-year median value for Preferred Dividend Payments was $163,822 (2018), whereas its average is $299,450.
  • Examining YoY changes over the last 5 years, Outlook Therapeutics' Preferred Dividend Payments showed a top increase of 10.38% in 2019 and a maximum decrease of 75.77% in 2019.
  • Over the past 5 years, Outlook Therapeutics' Preferred Dividend Payments (Quarterly) stood at $939,539 in 2015, then tumbled by 54.82% to $493,207 in 2016, then reached $450,801 in 2017, then crashed by 66.61% to $150,508 in 2018, then climbed by 10.38% to $166,133 in 2019.
  • Its Preferred Dividend Payments was $166,133 in Q4 2019, compared to $162,081 in Q3 2019 and $158,128 in Q2 2019.